VRCA - Verrica Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRCA is currently covered by 5 analysts with an average price target of $7.47. This is a potential upside of $6.86 (1124.59%) from yesterday's end of day stock price of $0.61.

Verrica Pharmaceuticals's activity chart (see below) currently has 36 price targets and 49 ratings on display. The stock rating distribution of VRCA is 8% HOLD and 92% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 8.93% with an average time for these price targets to be met of 46.71 days.

Highest price target for VRCA is $2, Lowest price target is $2, average price target is $5.2.

Most recent stock forecast was given by OREN LIVNAT from HC WAINWRIGHT on 06-Nov-2024. First documented stock forecast 21-Feb-2019.

Currently out of the existing stock ratings of VRCA, 2 are a HOLD (8%), 23 are a BUY (92%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$14

4 months 14 days ago
(06-Nov-2024)

0/13 (0%)

$4.51 (47.52%)

Hold

$12

4 months 15 days ago
(05-Nov-2024)

3/12 (25%)

$10.55 (727.59%)

169

Buy

$2

$0.99 (98.02%)

$11

4 months 15 days ago
(05-Nov-2024)

1/8 (12.5%)

$1.14 (132.56%)

79

Buy

$10

$8.99 (890.10%)

$10

1 years 3 months 5 days ago
(15-Dec-2023)

0/2 (0%)

$3.91 (64.20%)

Buy

$14

$12.99 (1286.14%)

$4

1 years 7 months 23 days ago
(25-Jul-2023)

1/4 (25%)

$8.68 (163.16%)

79

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VRCA (Verrica Pharmaceuticals) average time for price targets to be met?

On average it took 46.71 days on average for the stock forecasts to be realized with a an average price target met ratio 8.93

Which analyst has the current highest performing score on VRCA (Verrica Pharmaceuticals) with a proven track record?

SERGE BELANGER

Which analyst has the current lower performing score on VRCA (Verrica Pharmaceuticals) with a proven track record?

GLEN SANTANGELO

Which analyst has the most public recommendations on VRCA (Verrica Pharmaceuticals)?

Serge Belanger works at NEEDHAM and has 4 price targets and 9 ratings on VRCA

Which analyst is the currently most bullish on VRCA (Verrica Pharmaceuticals)?

Kemp Dolliver with highest potential upside - $16.47

Which analyst is the currently most reserved on VRCA (Verrica Pharmaceuticals)?

Serge Belanger with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?